CMS

Slide 3

A platform company

Linking pharmaceutical innovation and
commercialization with strong product
lifecycle management capability

Slide 1

Committed to building a pharmaceutical
ecosystem focused on delivering solutions in
an open and collaborative setting for
the benefit of all stakeholders

To fulfill unmet clinical needs

Slide 2

Providing competitive
products and services

To enable the more effective diagnosis
and treatment, whilst enhancing clinical
practice to the ultimate benefit of the patient

Innovation

Bio-technology incubation platform

Focusing on unmet clinical needs, we collaborate with global biotech/biopharma to jointly develop first- or best-in-class innovative products.

Business

Commercialization platform

Adhering to the patient-centered philosophy, we are dedicated to providing competitive products and services that enable the more effective diagnosis and treatment, whilst enhancing clinical practice to the ultimate benefit of the patient.

Cardio-cerebrovascular
and gastroenterology

Dermatology
and medical aesthetic

Ophthalmology

Southeast Asia Business

News

2024-08-15

Financial Performance Increased HoH, Entering “New Product Era” Successfully丨CMS(867.HK)2024 Interim Performance Report in One Picture

2024-08-05

China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China

2024-07-26

China Medical System: Ursodeoxycholic Acid Oral Suspension Approved for Marketing in China, Enhancing Accessibility of Medications for Pediatric and Rare Diseases

2024-07-16

China Medical System Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG “AA” Rating

Partnering

We collaborate with global innovative companies in flexible structures to jointly build a pharmaceutical ecosystem in a sustainable and collaborative setting for the benefit of all stakeholders.

Contact Us

If you are interested in joining us, or curious about our business and products, please feel free to contact us.